Ayşegül Akan, Emine Dibek Mısırlıoğlu, Ersoy Civelek, Can Naci Kocabaş
{"title":"Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.","authors":"Ayşegül Akan, Emine Dibek Mısırlıoğlu, Ersoy Civelek, Can Naci Kocabaş","doi":"10.1089/ped.2020.1334","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. <b><i>Objective:</i></b> To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. <b><i>Methods:</i></b> Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. <b><i>Results:</i></b> The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed \"well-controlled\", \"partially controlled\", and \"uncontrolled\" asthma, respectively, according to GINA. The patients with \"partially controlled\" and \"uncontrolled\" asthma were grouped as \"not well-controlled.\" The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining \"well-controlled\" asthma (<i>P</i> < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, <i>P</i> < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, <i>P</i> < 0.001 and κ = 0.151, <i>P</i> = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. <b><i>Conclusion:</i></b> ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.</p>","PeriodicalId":54389,"journal":{"name":"Pediatric Allergy Immunology and Pulmonology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664125/pdf/ped.2020.1334.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Allergy Immunology and Pulmonology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ped.2020.1334","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 3
Abstract
Background: Guidelines such as Global Initiative for Asthma (GINA) recommend disease control as the mainstay of asthma management. Objective: To investigate which measure of asthma control best correlates with the GINA criteria for determining asthma control in children. Methods: Child asthma-patients at a tertiary hospital were enrolled in the study after evaluation of response to treatment. Asthma control test (ACT)/pediatric asthma control test (PACT), Pediatric Asthma Quality of Life Questionnaire (PAQLQ), fractional exhaled nitric oxide (FeNO), and lung function parameters were evaluated. Patients were examined by asthma specialists and control status was evaluated based on GINA. Results: The median age (interquartile range) of patients was 10.7 (8.4-12.9) years, 57.9% of patients were boys. Of 228 children, 84.2%, 9.6%, and 6.1% displayed "well-controlled", "partially controlled", and "uncontrolled" asthma, respectively, according to GINA. The patients with "partially controlled" and "uncontrolled" asthma were grouped as "not well-controlled." The cutoff levels were 22, 21, and 5.9 for PACT, ACT, and PAQLQ, respectively, for determining "well-controlled" asthma (P < 0.001). With these cutoff values, ACT exhibited higher comparability with GINA than PACT and PAQLQ (κ = 0.473, 0.221, and 0.150, respectively, P < 0.001). PAQLQ had higher agreement with GINA criteria in children ≥12 years old (κ = 0.326, P < 0.001 and κ = 0.151, P = 0.014, respectively). Correctly classified patients with PACT, ACT, and PALQLQ based on GINA with these cutoff levels were 93 (64.1%), 63 (75.9%), and 139 (62.9%), respectively. FeNO and lung function parameters were unsuccessful at revealing control status according to GINA. Conclusion: ACT is better than PACT for comparability with GINA. Better correlation of PAQLQ and ACT and better comparability of PAQLQ and GINA were evident in older children.
背景:全球哮喘倡议(GINA)等指南建议将疾病控制作为哮喘管理的主要内容。目的:探讨确定儿童哮喘控制的GINA标准与哮喘控制的最佳相关性。方法:对某三级医院的儿童哮喘患者进行治疗效果评价,纳入研究。评估哮喘控制试验(ACT)/儿童哮喘控制试验(PACT)、儿童哮喘生活质量问卷(PAQLQ)、呼气一氧化氮分数(FeNO)和肺功能参数。患者由哮喘专家检查,并根据GINA评估控制状况。结果:患者中位年龄(四分位数间距)为10.7(8.4 ~ 12.9)岁,男孩占57.9%。在228名儿童中,84.2%、9.6%和6.1%分别表现出“良好控制”、“部分控制”和“未控制”的哮喘。“部分控制”和“未控制”的哮喘患者被归为“控制不好”。用于判定“控制良好”哮喘的PACT、ACT和PAQLQ的临界值分别为22、21和5.9 (P P P P分别= 0.014)。基于GINA正确分类PACT、ACT和PALQLQ患者,这些截止水平分别为93(64.1%)、63(75.9%)和139(62.9%)。根据GINA, FeNO和肺功能参数不能显示控制状态。结论:ACT与GINA的可比性优于PACT。PAQLQ与ACT有较好的相关性,PAQLQ与GINA有较好的可比性。
期刊介绍:
Pediatric Allergy, Immunology, and Pulmonology is a peer-reviewed journal designed to promote understanding and advance the treatment of respiratory, allergic, and immunologic diseases in children. The Journal delivers original translational, clinical, and epidemiologic research on the most common chronic illnesses of children—asthma and allergies—as well as many less common and rare diseases. It emphasizes the developmental implications of the morphological, physiological, pharmacological, and sociological components of these problems, as well as the impact of disease processes on families.
Pediatric Allergy, Immunology, and Pulmonology coverage includes:
-Functional and genetic immune deficiencies-
Interstitial lung diseases-
Both common and rare respiratory, allergic, and immunologic diseases-
Patient care-
Patient education research-
Public health policy-
International health studies